Diluted EPS came in at $-2.76.
Filings will appear here once submitted to SEC EDGAR.
Common questions about Galmed Pharmaceuticals's Q1 2024 earnings report.
Galmed Pharmaceuticals (GLMD) reported Q1 2024 earnings on May 30, 2024 before market open.
Galmed Pharmaceuticals reported diluted EPS of $-2.76 for Q1 2024.